News
Award of Share Options
6 March 2014
TyraTech, Inc. (AIM: TYR), a natural life sciences company, announces that on 4 March 2013, a total of 2,500,000 Stock Appreciation Right options over common shares of US$0.001 in the Company ("SARs"), were awarded to the directors of the Company (the "Award").
Of the SARs awarded, Bruno Jactel, Alan Reade, Barry Riley and James Hills, directors of the Company, were awarded 1,500,000, 500,000, 250,000 and 250,000 SARs, respectively.
The Company now has a total of 10,676,909 SARs outstanding over Common shares.
Following the Award:
Bruno Jactel is interested in 1,859,567 Common Shares representing an interest of 0.90 per cent. of the total voting rights of the Company. In addition, Bruno Jactel is interested in 1,500,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 1,500,000 | 12.5p | 4 March 2024 |
Alan Reade is interested in 12,486,358 Common Shares representing an interest of 6.06 per cent. of the total voting rights of the Company. In addition, Alan Reade is interested in 3,145,695 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 500,000 | 12.5p | 4 March 2024 |
| 1,000,000 | 6p | 25 April 2022 |
| 100,570 | 12p | 6 March 2022 |
| 550,000 | 10.5p | 4 February 2020 |
| 995,125 | 12p | 10 October 2020 |
Barry Riley is interested in 3,055,556 Common Shares in the Company representing an interest of up to 1.48 per cent. of the total voting rights of the Company. In addition, Barry Riley is interested in 800,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 250,000 | 12.5p | 4 March 2024 |
| 350,000 | 6p | 25 April 2022 |
| 200,000 | 12p | 10 October 2020 |
James Hills is interested in 1,047,900 Common Shares in the Company representing an interest of up to 0.51 per cent. of the total voting rights of the Company. In addition, James Hills is interested in 800,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 250,000 | 12.5p | 4 March 2024 |
| 350,000 | 6p | 25 April 2022 |
| 200,000 | 12p | 10 October 2020 |
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Peter Jerome, Chief Financial Officer |
Tel: +44 7841978709 Tel: +1 919 415 4280 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: +44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald Mc-Gregor Smith / Niall Devins |
Tel: +44 20 7087 4555 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.